CytomX Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

<p>SOUTH SAN FRANCISCO, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today announced that Sean McCarthy, D.Phil., president, chief executive officer, and chairman, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024 at 5:15 p.m. […]</p>
<p>The post <a href="https://forextv.com/top-news/cytomx-therapeutics-to-present-at-the-42nd-annual-j-p-morgan-healthcare-conference/">CytomX Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>